Skip to main content
Find more clinical trials

Communicating Amyloid Neuroimaging (REVEAL-SCAN)

Start: November 2016
End: December 2020
Enrollment: 270

What Is This Study About?

This study examines the impact on older adults of learning the results of amyloid brain imaging, which can indicate risk for Alzheimer's disease. 

Do I Qualify To Participate in This Study?

Minimum Age: 65 Years

Maximum Age: 80 Years

Must have:

  • At least one first-degree relative (parent, sibling, child) with Alzheimer's disease
  • Study partner who will complete surveys and interviews and accompany subject to visits
  • Willingness to give a cheek swab for Alzheimer's-related genetic testing
  • English speaking

Must NOT have:

  • History of stroke or head trauma
  • Active medical or psychiatric illness that is unstable or progressive
  • Taking memantine

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

Study Contact
Alexandra Hempel, BA
617-264-5876
ahempel@bwh.harvard.edu

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Massachusetts
Brigham and Women's Hospital
Boston, MA 02115
Michigan
University of Michigan
Ann Arbor, MI 48109
North Carolina
Duke University
Durham, NC 27705
Pennsylvania
University of Pennsylvania
Philadelphia, PA 19104

Who Sponsors This Study?

Lead: Brigham and Women's Hospital

Collaborator Sponsor

  • University of Pennsylvania
  • University of Michigan
  • Duke University
  • Boston University
  • National Institute on Aging (NIA)

Source: ClinicalTrials.gov ID: NCT02959489